Embracing AI in Drug Development: FDA’s Pioneering Step
The FDA’s new draft guidance on AI in drug and medical device development marks a transformative step in healthcare. By setting clear standards, the agency aims to streamline innovation while ensuring patient safety, heralding a new era of AI-driven medical advancements.